The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.
Compacted DNA Nanoparticles Administered to the Nasal Mucosa of Cystic Fibrosis Subjects Are Safe and Demonstrate Partial to Complete Cystic Fibrosis Transmembrane Regulator Reconstitution
Abstract
A double-blind, dose escalation gene transfer trial was conducted in subjects with cystic fibrosis (CF), among whom placebo (saline) or compacted DNA was superfused onto the inferior turbinate of the right or left nostril. The vector consisted of single molecules of plasmid DNA carrying the cystic fibrosis transmembrane regulator- encoding gene compacted into DNA nanoparticles, using polyethylene glycol-substituted 30-mer lysine peptides. Entry criteria included age greater than 18 years, FEV1 exceeding 50% predicted, and basal nasal potential difference (NPD) isoproterenol responses (> or = -5 mV) that are typical for subjects with classic CF. Twelve subjects were enrolled: 2 in dose level I (DLI) (0.8 mg DNA), 4 in DLII (2.67 mg), and 6 in DLIII (8.0 mg). The primary trial end points were safety and tolerability, and secondary gene transfer end points were assessed. In addition to routine clinical assessments and laboratory tests, subjects were serially evaluated for serum IL-6, complement, and C-reactive protein; nasal washings were taken for cell counts, protein, IL-6, and IL-8; and pulmonary function and hearing tests were performed. No serious adverse events occurred, and no events were attributed to compacted DNA. There was no association of serum or nasal washing inflammatory mediators with administration of compacted DNA. Day 14 vector polymerase chain reaction analysis showed a mean value in DLIII nasal scraping samples of 0.58 copy per cell. Partial to complete NPD isoproterenol responses were observed in eight subjects: one of two in DLI, three of four in DLII, and four of six in DLIII. Corrections persisted for as long as 6 days (1 subject to day 28) after gene transfer. In conclusion, compacted DNA nanoparticles can be safely administered to the nares of CF subjects, with evidence of vector gene transfer and partial NPD correction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the Cystic Fibrosis Gene: Cloning and Characterization of Complementary DNA
Riordan, J. R., Rommens, J. M., Kerem, B.-S., Alon, N., Rozmahel, R., Grzelczak, Z., Zielenski, J., Lok, S., Plavsic, N., Chou, J.-L., et al. (1989) · Science · doi:10.1126/science.2475911 · Cited by 7,418
Identification of the Cystic Fibrosis Gene: Genetic Analysis
Kerem, B.-S., Rommens, J. M., Buchanan, J. A., Markiewicz, D., Cox, T. K., Chakravarti, A., Buchwald, M., & Tsui, L.-C. (1989) · Science · doi:10.1126/science.2570460 · Cited by 4,142
Identification of the Cystic Fibrosis Gene: Chromosome Walking and Jumping
Rommens, J. M., Iannuzzi, M. C., Kerem, B.-S., Drumm, M. L., Melmer, G., Dean, M., Rozmahel, R., Cole, J. L., Kennedy, D., Hidaka, N., et al. (1989) · Science · doi:10.1126/science.2772657 · Cited by 3,253
Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice
Mall, M., Grubb, B. R., Harkema, J. R., O'Neal, W. K., & Boucher, R. C. (2004) · Nature Medicine · doi:10.1038/nm1028 · Cited by 911
Crystal, R. G., McElvaney, N. G., Rosenfeld, M. A., Chu, C.-S., Mastrangeli, A., Hay, J. G., Brody, S. L., Jaffe, H. A., Eissa, N. T., & Danel, C. (1994) · Nature Genetics · doi:10.1038/ng0994-42 · Cited by 826
Davis, P. B., Drumm, M., & Konstan, M. W. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.154.5.8912731 · Cited by 764
Self-citationLiposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
Caplen, N. J., Alton, E. W. F. W., Mddleton, P. G., Dorin, J. R., Stevenson, B. J., Gao, X., Durham, S. R., Jeffery, P. K., Hodson, M. E., Coutelle, C., et al. (1995) · Nature Medicine · doi:10.1038/nm0195-39 · Cited by 711
Metabolic instability of plasmid DNA in the cytosol: a potential barrier to gene transfer
Lechardeur, D., Sohn, K.-J., Haardt, M., Joshi, P. B., Monck, M., Graham, R. W., Beatty, B., Squire, J., O’Brodovich, H., & Lukacs, G. L. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300867 · Cited by 633
Plank, C., Mechtler, K., Szoka, F. C., & Wagner, E. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.12-1437 · Cited by 583
Correction of the cystic fibrosis defect in vitro by retrovirus-mediated gene transfer
Drumm, M. L., Pope, H. A., Cliff, W. H., Rommens, J. M., Marvin, S. A., Tsui, L.-C., Collins, F. S., Frizzell, R. A., & Wilson, J. M. (1990) · Cell · doi:10.1016/0092-8674(90)90398-x · Cited by 576
Knowles, M. R., Hohneker, K. W., Zhou, Z., Olsen, J. C., Noah, T. L., Hu, P.-C., Leigh, M. W., Engelhardt, J. F., Edwards, L. J., Jones, K. R., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331302 · Cited by 566
Management of Pulmonary Disease in Patients with Cystic Fibrosis
Ramsey, B. W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350307 · Cited by 502
Identification of the cystic fibrosis gene.
Knight, R. A., & Hodson, M. E. (1990) · BMJ · doi:10.1136/bmj.300.6721.345 · Cited by 496
Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis
Johnson, L. G., Olsen, J. C., Sarkadi, B., Moore, K. L., Swanstrom, R., & Boucher, R. C. (1992) · Nature Genetics · doi:10.1038/ng0992-21 · Cited by 439
Correction of the ion transport defect in cystic fibrosis transgenic mice by gene therapy
Hyde, S. C., Gill, D. R., Higgins, C. F., Trezise, A. E. O., MacVinish, L. J., Cuthbert, A. W., Ratcliff, R., Evans, M. J., & Colledge, W. H. (1993) · Nature · doi:10.1038/362250a0 · Cited by 435
Alton, E., Stern, M., Farley, R., Jaffe, A., Chadwick, S., Phillips, J., Davies, J., Smith, S., Browning, J., Davies, M., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)06532-5 · Cited by 435
Moss, R. B., Rodman, D., Spencer, L. T., Aitken, M. L., Zeitlin, P. L., Waltz, D., Milla, C., Brody, A. S., Clancy, J. P., Ramsey, B., et al. (2004) · Chest · doi:10.1378/chest.125.2.509 · Cited by 390
Lukacs, G. L., Chang, X. B., Bear, C., Kartner, N., Mohamed, A., Riordan, J. R., & Grinstein, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)80582-1 · Cited by 387
Porteous, D., Dorin, Jr., McLachlan, G., Davidson-Smith, H., Davidson, H., Stevenson, B., Carothers, A., Wallace, W., Moralee, S., Hoenes, C., et al. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300390 · Cited by 324
Qin, L., Ding, Y., Pahud, D. R., Chang, E., Imperiale, M. J., & Bromberg, J. S. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.17-2019 · Cited by 315
Knowles, M. R., Paradiso, A. M., & Boucher, R. C. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.4-445 · Cited by 308
Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy
Jooss, K., & Chirmule, N. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302037 · Cited by 277
Wagner, J. A., Nepomuceno, I. B., Messner, A. H., Moran, M. L., Batson, E. P., Dimiceli, S., Brown, B. W., Desch, J. K., Norbash, A. M., Conrad, C. K., et al. (2002) · Human Gene Therapy · doi:10.1089/104303402760128577 · Cited by 266
Zabner, J., Ramsey, B. W., Meeker, D. P., Aitken, M. L., Balfour, R. P., Gibson, R. L., Launspach, J., Moscicki, R. A., Richards, S. M., & Standaert, T. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118573 · Cited by 265
Gill, D., Southern, K., Mofford, K., Seddon, T., Huang, L., Sorgi, F., Thomson, A., MacVinish, L., Ratcliff, R., Bilton, D., et al. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300391 · Cited by 263
Reactivation of silenced, virally transduced genes by inhibitors of histone deacetylase
Chen, W. Y., Bailey, E. C., McCune, S. L., Dong, J.-Y., & Townes, T. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5798 · Cited by 256
CpG motifs in bacterial DNA cause inflammation in the lower respiratory tract.
Schwartz, D. A., Quinn, T. J., Thorne, P. S., Sayeed, S., Yi, A. K., & Krieg, A. M. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119523 · Cited by 254
Scheule, R. K., George, J. A. S., Bagley, R. G., Marshall, J., Kaplan, J. M., Akita, G. Y., Wang, K. X., Lee, E. R., Harris, D. J., Jiang, C., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.6-689 · Cited by 251
Flotte, T. R., Zeitlin, P. L., Reynolds, T. C., Heald, A. E., Pedersen, P., Beck, S., Conrad, C. K., Brass-Ernst, L., Humphries, M., Sullivan, K., et al. (2003) · Human Gene Therapy · doi:10.1089/104303403322124792 · Cited by 246
Harvey, B.-G., Leopold, P. L., Hackett, N. R., Grasso, T. M., Williams, P. M., Tucker, A. L., Kaner, R. J., Ferris, B., Gonda, I., Sweeney, T. D., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7935 · Cited by 245
Aitken, M. L., Moss, R. B., Waltz, D. A., Dovey, M. E., Tonelli, M. R., McNamara, S. C., Gibson, R. L., Ramsey, B. W., Carter, B. J., & Reynolds, T. C. (2001) · Human Gene Therapy · doi:10.1089/104303401753153956 · Cited by 239
Trapnell, B. C., Chu, C. S., Paakko, P. K., Banks, T. C., Yoshimura, K., Ferrans, V. J., Chernick, M. S., & Crystal, R. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.15.6565 · Cited by 232
Efficient and persistent gene transfer of AAV-CFTR in maxillary sinus
Wagner, J. A., Reynolds, T., Moran, M. L., Moss, R. B., Wine, J. J., Flotte, T. R., & Gardner, P. (1998) · The Lancet · doi:10.1016/s0140-6736(05)77740-0 · Cited by 225
Tsutsumi, Y., Onda, M., Nagata, S., Lee, B., Kreitman, R. J., & Pastan, I. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.140210597 · Cited by 216
Immune responses to adeno-associated virus and its recombinant vectors.
Sun, J. Y., Anand-Jawa, V, Chatterjee, S., & Wong, K. K. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302039 · Cited by 215
Gill, D., Smyth, S., Goddard, C., Pringle, I., Higgins, C., Colledge, W., & Hyde, S. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301561 · Cited by 214
Wagner, J. A., Messner, A. H., Moran, M. L., Daifuku, R., Kouyama, K., Desch, J. K., Manley, S., Norbash, A. M., Conrad, C. K., Friborg, S., et al. (1999) · The Laryngoscope · doi:10.1097/00005537-199902000-00017 · Cited by 210
Yew, N. S., Wang, K. X., Przybylska, M., Bagley, R. G., Stedman, M., Marshall, J., Scheule, R. K., & Cheng, S. H. (1999) · Human Gene Therapy · doi:10.1089/10430349950019011 · Cited by 205
Chirmule, N., Xiao, W., Truneh, A., Schnell, M. A., Hughes, J. V., Zoltick, P., & Wilson, J. M. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2420-2425.2000 · Cited by 198
Conrad, C., Allen, S. S., Afione, S. A., Reynolds, T. C., Beck, S. E., Fee-Maki, M., Barraza-Ortiz, X., Adams, R. J., Askin, F. B., Carter, B. J., et al. (1996) · PubMed · Cited by 196
Nanoparticles of Compacted DNA Transfect Postmitotic Cells
Liu, G., Li, D., Pasumarthy, M. K., Kowalczyk, T. H., Gedeon, C. R., Hyatt, S. L., Payne, J. M., Miller, T. J., Brunovskis, P., Fink, T. L., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305776200 · Cited by 190
Self-citationRuiz, F. E., Clancy, J. P., Perricone, M. A., Bebok, Z., Hong, J. S., Cheng, S. H., Meeker, D. P., Young, K. R., Schoumacher, R. A., Weatherly, M. R., et al. (2001) · Human Gene Therapy · doi:10.1089/104303401750148667 · Cited by 185
Zabner, J., Cheng, S. H., Meeker, D., Launspach, J., Balfour, R., Perricone, M. A., Morris, J. E., Marshall, J., Fasbender, A., Smith, A. E., et al. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119676 · Cited by 176
Gene therapy progress and prospects: cystic fibrosis
Griesenbach, U., Geddes, D. M., Alton, E. W. F. W., & on behalf of the UK Cystic Fibrosis Gene Therapy Consortium (2006) · Gene Therapy · doi:10.1038/sj.gt.3302809 · Cited by 175
Yei, S., Mittereder, N., Wert, S., Whitsett, J. A., Wilmott, R. W., & Trapnell, B. C. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.6-731 · Cited by 172
Transfection of airway epithelium by stable PEGylated poly-l-lysine DNA nanoparticles in vivo
Ziady, A.-G., Gedeon, C. R., Miller, T., Quan, W., Payne, J. M., Hyatt, S. L., Fink, T. L., Muhammad, O., Oette, S., Kowalczyk, T., et al. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.07.007 · Cited by 165
Self-citationZuckerman, J. B., Robinson, C. B., M, K. S., SHELL, R. D., Sferra, T. J., Chirmule, N. B., Magosin, S., PROPERT, K. J., Brown-Parr, E. C., Hughes, J. V., et al. (1999) · Human Gene Therapy · doi:10.1089/10430349950016384 · Cited by 156
Ca2+-sensitive cytosolic nucleases prevent efficient delivery to the nucleus of injected plasmids
Pollard, H., Toumaniantz, G., Amos, J.-L., Avet‐Loiseau, H., Guihard, G., Behr, J., & Escande, D. (2001) · The Journal of Gene Medicine · doi:10.1002/jgm.160 · Cited by 148
Protocols for in vivo measurement of the ion transport defects in cystic fibrosis nasal epithelium
Middleton, P. G., Geddes, D. M., & Alton, E. W. F. W. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07112050 · Cited by 145
Dorin, J. R., Farley, R., Webb, S., Smith, S. N., Farini, E., Delaney, S. J., Wainwright, B. J., Alton, E. W. F. W., & Porteous, D. J. (1996) · PubMed · Cited by 144
Status of gene therapy for cystic fibrosis lung disease
Boucher, R. C. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6330 · Cited by 136
Hay, J. G., McElvaney, N. G., Herena, J., & Crystal, R. G. (1995) · Human Gene Therapy · doi:10.1089/hum.1995.6.11-1487 · Cited by 136
Inactivation of the Very Strong HCMV Immediate Early Promoter by DNA CpG MethylationIn Vitro
Prösch, S., Stein, J., Staak, K., Liebenthal, C., Volk, H., & Krüger, D. H. (1996) · Biological Chemistry Hoppe-Seyler · doi:10.1515/bchm3.1996.377.3.195 · Cited by 129
Chaffee, S., Mary, A., Stiehm, E. R., Girault, D., Fischer, A., & Hershfield, M. S. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115761 · Cited by 111
Heda, G. D., Tanwani, M., & Marino, C. R. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.1.c166 · Cited by 111
Middleton, P. G., Caplen, N. J., Gao, X., Huang, L., Gaya, H., Geddes, D. M., & Alton, E. W. F. W. (1994) · European Respiratory Journal · doi:10.1183/09031936.94.07030442 · Cited by 108
Interferon-gamma downregulates CFTR gene expression in epithelial cells
Besançon, F., Przewlocki, G., Baró, I., Hongre, A. S., Escande, D., & Edelman, A. (1994) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1994.267.5.c1398 · Cited by 104
König, J. C., Schreiber, R., Voelcker, T., et al. (2001) · EMBO Reports · doi:10.1093/embo-reports/kve232 · Cited by 100
Cationic Proteins Induce Airway Hyperresponsiveness Dependent on Charge Interactions
Coyle, A. J., Ackerman, S. J., & Irvin, C. G. (1993) · American Review of Respiratory Disease · doi:10.1164/ajrccm/147.4.896 · Cited by 96
Goldman, M. J., Yang, Y., & Wilson, J. M. (1995) · Nature Genetics · doi:10.1038/ng0295-126 · Cited by 96
Minimal toxicity of stabilized compacted DNA nanoparticles in the murine lung
Ziady, A. G., Gedeon, C. R., Muhammad, O., Stillwell, V., Oette, S. M., Fink, T. L., Quan, W., Kowalczyk, T. H., Hyatt, S. L., Payne, J. M., et al. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.09.002 · Cited by 93
Self-citationKonstan, M. W., & Davis, P. B. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00146-1 · Cited by 72
Self-citationZiady, A. G., Kelley, T. J., Milliken, E. L., Ferkol, T. W., & Davis, P. B. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0556 · Cited by 68
Self-citationInterleukin-1β regulates CFTR expression in human intestinal T84 cells
Cafferata, E. G. A., González-Guerrico, A. M., Giordano, L., Pivetta, O. H., & Santa-Coloma, T. A. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(99)00105-2 · Cited by 66
Wilmott, R. W., Amin, R. S., Perez, C. R., Wert, S. E., Keller, G., Boivin, G. P., Hirsch, R., de Inocencio, J., Lu, P., Reising, S. F., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.3-301 · Cited by 63
Gene Therapy for Cystic Fibrosis
Mueller, C., & Flotte, T. R. (2008) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-008-8080-3 · Cited by 60
Relation of sweat chloride concentration to severity of lung disease in cystic fibrosis
Davis, P. B., SCHLUCHTER, M. D., & Konstan, M. W. (2004) · Pediatric Pulmonology · doi:10.1002/ppul.20054 · Cited by 51
Self-citationGene transfer for cystic fibrosis
Welsh, M. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8634 · Cited by 47
Wang, D., Buyon, J. P., Zhu, W., & Chan, E. K. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8003 · Cited by 39
Flotte, T. R., Schwiebert, E. M., Zeitlin, P. L., Carter, B. J., & Guggino, W. B. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.921 · Cited by 38
Emerging drug treatments for cystic fibrosis
Zeitlin, P. L. (2003) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.8.2.523 · Cited by 32
Cited by
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Nonviral vectors for gene delivery
Mintzer, M. A., & Simanek, E. E. (2009) · Chemical Reviews · doi:10.1021/cr800409e · Cited by 2,366
Block copolymer micelles in nanomedicine applications
Cabral, H., Miyata, K., Osada, K., & Kataoka, K. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00199 · Cited by 1,309
Nonviral Gene Delivery: Principle, Limitations, and Recent Progress
Al-Dosari, M. S., & Gao, X. (2009) · The AAPS Journal · doi:10.1208/s12248-009-9143-y · Cited by 706
Metadata
- Authors
- Konstan, M. W., Davis, P. B., Wagener, J. S., Hilliard, K. A., Stern, R. C., Milgram, L. J. H., Kowalczyk, T. H., Hyatt, S. L., Fink, T. L., Gedeon, C. R., Oette, S. M., Payne, J. M., Muhammad, O., Ziady, A. G., Moen, R. C., & Cooper, M. J.
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 2004-12
- Volume
- 15
- Issue
- 12
- Pages
- 1255-1269
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2081571534
- Cited by
- 298
- References
- 71
- FWCI
- 9.63
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.